Supplemental Digital Content is Available in the Text.
Metabolic profiling coupled with extreme sampling identified lysophosphatidylcholines 26:0 and 28:1 to be potential biomarkers for multisite musculoskeletal pain.
Introduction Up to one third of total joint replacement patients (TJR) experience poor surgical outcome. Objectives To identify metabolomic signatures for non-responders to TJR in primary osteoarthritis (OA) patients. Methods A newly developed differential correlation network analysis method was applied to our previously published metabolomic dataset to identify metabolomic network signatures for non-responders to TJR. Results Differential correlation networks involving 12 metabolites and 23 metabolites were identified for pain non-responders and function non-responders, respectively. Conclusion The differential networks suggest that inflammation, muscle breakdown, wound healing, and metabolic syndrome may all play roles in TJR response, warranting further investigation.
Objectives
Knee pain is the major driver for osteoarthritis (OA) patients to seek healthcare; but after pursuing both conservative and surgical pain interventions, approximately 20% of patients continue to report long-term pain following total knee arthroplasty (TKA). The study aimed to identify a metabolomic signature for sustained knee pain after TKA to elucidate possible underlying mechanisms.
Methods
Two independent cohorts from St. John’s, NL, Canada (n = 430), and Toronto, ON, Canada (n = 495) were included in the study. Sustained knee pain was assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale (five questions) at least one year after TKA for primary OA. Those reporting any pain on all five questions were considered to have sustained knee pain. Metabolomic profiling was performed on fasted pre-operative plasma samples using the Biocrates Absolute IDQ p180 kit. Associations between metabolites and pair-wise metabolite ratios with sustained knee pain in each individual cohort were assessed using logistic regression with adjustment for age, sex, and BMI. Random-effects meta-analysis using inverse variance as weights was performed on summary statistics from both cohorts.
Results
One metabolite, phosphatidylcholine (PC) diacyl (aa) C28:1 (OR = 0.66, p = 0.00026), and three metabolite ratios, PC aa C32:0 to PC aa C28:1, PC aa C28:1 to PC aa C32:0, and tetradecadienylcarnitine (C14:2) to sphingomyelin C20:2 (ORs=1.59, 0.60, and 1.59, respectively; all p < 2 × 10−5), were significantly associated with sustained knee pain.
Conclusions
Though further investigations are needed, our results provide potential predictive biomarkers and drug targets that could serve as a marker for poor response and be modified pre-operatively to improve knee pain and surgical response to TKA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.